It found that only 11% of patients receiving Dex developed cerebral hyperperfusion, compared to 38% in a placebo group. Only 3% of patients went on to develop cerebral hyperperfusion syndrome, ...

Grey Wolf Animal Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified animal health company, ...

BACKGROUND: Dexmedetomidine is an α 2-receptor agonist used for sedation in the intensive care unit (ICU). Although dexmedetomidine is labeled for sedation in critically ill patients at doses up ...

Objectives: Although generally effective for sedation during noninvasive procedures, dexmedetomidine as the sole agent has not been uniformly successful for invasive procedures. To overcome some ...

TPU-006 is an investigational 4-day dexmedetomidine transdermal system, a novel drug delivery technology with a non-opioid active moiety for managing post-surgical pain. "We are excited by the FDA ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

1. Why am I being treated with PRECEDEX? PRECEDEX contains the active ingredient dexmedetomidine hydrochloride. PRECEDEX can be used as a sedative (calming agent) if adults need to be calm or ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...